Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the assessed public health impact of DNA contamination in Pfizer's mRNA vaccines by the end of 2025?
Significant negative impact • 25%
Minor negative impact • 25%
No impact • 25%
Positive impact • 25%
Reports from public health organizations or peer-reviewed journals
FDA Study by Student Researchers Finds DNA Contamination in Pfizer's mRNA Vaccines Exceeds Limits by 6 to 470 Times
Jan 3, 2025, 06:17 AM
Recent studies and reports have raised concerns about the presence of DNA contamination in Pfizer's mRNA COVID-19 vaccines. A study conducted at the FDA's White Oak Campus in Maryland by student researchers found that residual DNA levels in the vaccines exceeded regulatory safety limits by 6 to 470 times. The vaccine vials were sourced from BEI Resources, affiliated with the National Institute of Allergy and Infectious Diseases. The findings, published in the Journal of High School Science, challenge previous dismissals by regulatory authorities regarding concerns about DNA contamination. The FDA has yet to issue a public alert or recall the affected batches. The study used NanoDrop and Qubit analyses to confirm the presence of DNA contamination, aligning with reports from independent laboratories in several countries. Kevin McKernan, a former director of the Human Genome Project, criticized the FDA for a lack of transparency, while Nikolai Petrovsky, a Professor of Immunology, described the findings as a 'smoking gun.' Experts have highlighted potential cancer-causing mechanisms related to the contamination.
View original story
Investigation inconclusive • 25%
No significant contamination found • 25%
Contamination confirmed, no recall • 25%
Contamination confirmed, recall issued • 25%
Warning issued • 25%
Recall issued • 25%
Investigation initiated • 25%
No action taken • 25%
Decreased trust in mRNA vaccines • 25%
Increased trust in mRNA vaccines • 25%
Mixed opinions • 25%
Trust remains unchanged • 25%
No issues found • 25%
Minor issues found • 25%
Significant issues found • 25%
Undetermined • 25%
Major impact • 25%
Moderate impact • 25%
Minor impact • 25%
No impact • 25%
Mixed impact • 25%
Increase trust • 25%
Decrease trust • 25%
No significant change • 25%
Mostly positive • 25%
Unchanged • 25%
Mixed • 25%
Mostly negative • 25%
Increased transparency and trust • 25%
No significant impact • 25%
Policy changes in vaccine approval • 25%
Legal challenges against FDA • 25%
Mostly negative • 25%
Indifferent • 25%
Mostly positive • 25%
Mixed • 25%
No decision • 25%
Withdrawn • 25%
Approved • 25%
Rejected • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Safety limits updated • 25%
Other outcome • 25%
Recall issued • 25%
No action taken • 25%